Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
about
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Final Results of the Randomize ...... tive Metastatic Breast Cancer.
@en
type
label
Final Results of the Randomize ...... tive Metastatic Breast Cancer.
@en
prefLabel
Final Results of the Randomize ...... tive Metastatic Breast Cancer.
@en
P2093
P1476
Final Results of the Randomize ...... tive Metastatic Breast Cancer.
@en
P2093
Agusti Barnadas
An Vandebroek
Arlene Chan
Daniel Rauch
Gustavo Villanova
Kadri Altundag
Michiel Botha
Nicole Tubiana-Mathieu
Patricia Dodyk
Saverio Cinieri
P304
P356
10.1016/J.CLBC.2016.06.014
P407
P577
2016-06-25T00:00:00Z